| Expression pattern: |
UP |
| Associated gene: |
PHF19 |
| Associated microRNA: |
hsa-mir-3620-5p |
| Biological function: |
hsa_circ_0002360 is aberrantly and abundantly expressed in LAC tissues and may participate in the development and pathogenesis of LAC. |
| Molecular mechanism: |
Predicted circRNA-miRNA-mRNA regulatory mechanism in which upregulated hsa_circ_0002360 may inhibit hsa-mir-3620-5p and thereby increase PHF19 expression. |
| Biological pathway or process: |
ceRNA regulation (promotes); other pathway/process (promotes) |
| Detected method: |
Q
S
|
| Validation methods: |
divergent primers PCR; RNase R Treatment; circRNA-seq; RT-qPCR; Clinical Sample Validation; Western Blot; IHC (Immunohistochemistry); Bioinformatics Analysis; RNA-seq |
| Clinical significance: |
hsa_circ_0002360 may be a valuable therapeutic target for LAC treatment. |
| Description: |
This study identifies hsa_circ_0002360 as an up-regulated circRNA in human lung adenocarcinoma tissues, validated by qRT-PCR after circRNA sequencing. The authors propose a hsa_circ_0002360/hsa-mir-3620-5p/PHF19 regulatory axis, in which increased hsa_circ_0002360 may suppress hsa-mir-3620-5p and increase PHF19 expression, contributing to LAC pathogenesis and suggesting therapeutic potential. |
| Confidence score: |
0.7352 |